The Neuromuscular Clues to a Rare Rheumatic Syndrome
A new review in the Journal of Neurology, Neurosurgery & Psychiatry provides a crucial neuromuscular perspective on POEMS syndrome, a rare multisystemic disorder linked to plasma cell dyscrasia. The article details how this condition, characterized by Polyneuropathy, Organomegaly, Endocrinopathy, M-protein, and Skin changes, most commonly presents with a demyelinating peripheral neuropathy that is frequently misdiagnosed as chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Accurate differentiation hinges on recognizing specific clinical, neurophysiological, and imaging features, alongside elevated vascular endothelial growth factor (VEGF) levels, which disrupt the blood-nerve barrier. Treatment strategies, ranging from radiotherapy to autologous stem cell transplantation, depend on disease extent, with early intervention being paramount to prevent irreversible nerve damage and improve long-term functional outcomes for patients.
Study Significance: For rheumatologists, this review underscores the importance of considering POEMS syndrome in the differential diagnosis of complex, inflammatory, and autoimmune-like presentations, particularly when neuropathy is a prominent feature. Understanding the central role of VEGF and the distinct diagnostic pathway can prevent delays in managing this systemic condition, which shares therapeutic overlaps with other hematologic-rheumatic disorders. This knowledge is essential for refining multidisciplinary diagnostic approaches and selecting targeted therapies that address the underlying plasma cell dyscrasia.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
